Fidelity Investments’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $48.3M | Buy |
4,835,383
+4,834,990
| +1,230,277% | +$48.3M | ﹤0.01% | 1414 |
|
2025
Q1 | $34.5K | Sell |
393
-5
| -1% | -$439 | ﹤0.01% | 4022 |
|
2024
Q4 | $36.9K | Sell |
398
-1,971
| -83% | -$183K | ﹤0.01% | 3984 |
|
2024
Q3 | $173K | Buy |
2,369
+2,365
| +59,125% | +$173K | ﹤0.01% | 3240 |
|
2024
Q2 | $254 | Sell |
4
-15,354
| -100% | -$975K | ﹤0.01% | 4905 |
|
2024
Q1 | $15.9M | Buy |
15,358
+1
| +0% | +$1.04K | ﹤0.01% | 1732 |
|
2023
Q4 | $12.2M | Buy |
15,357
+227
| +2% | +$180K | ﹤0.01% | 1787 |
|
2023
Q3 | $7.19M | Sell |
15,130
-5,659
| -27% | -$2.69M | ﹤0.01% | 1928 |
|
2023
Q2 | $12.5M | Buy |
20,789
+4,476
| +27% | +$2.69M | ﹤0.01% | 1790 |
|
2023
Q1 | $11.5M | Buy |
16,313
+3,251
| +25% | +$2.3M | ﹤0.01% | 1819 |
|
2022
Q4 | $13.4M | Sell |
13,062
-1,940
| -13% | -$1.99M | ﹤0.01% | 1777 |
|
2022
Q3 | $8.71M | Sell |
15,002
-3,134
| -17% | -$1.82M | ﹤0.01% | 1964 |
|
2022
Q2 | $9.92M | Sell |
18,136
-2,420
| -12% | -$1.32M | ﹤0.01% | 1971 |
|
2022
Q1 | $13.2M | Buy |
20,556
+32
| +0.2% | +$20.5K | ﹤0.01% | 2005 |
|
2021
Q4 | $8.47M | Hold |
20,524
| – | – | ﹤0.01% | 2178 |
|
2021
Q3 | $15.1M | Sell |
20,524
-5,071
| -20% | -$3.72M | ﹤0.01% | 1958 |
|
2021
Q2 | $22.2M | Buy |
+25,595
| New | +$22.2M | ﹤0.01% | 1809 |
|